International Journal of Drug Delivery Technology
Volume 16, Issue 2s

Pharmacological Characterization of a Substituted Pyrrolizidine Derivative as a Dual Inhibitor of JAK1 Kinase and Pseudokinase Domains in Hepatocellular Carcinoma

Supritha G Swamy1, Vijay Ramesh2, Meghashree Gangatikar2, Sathyamurthy Srinivasa2, Babu Shubha Priya3, Ranjith Siddaraju3, Chandan Shivamallu4, Hema B. P1, Bhargav Shreevatsa2*, Nanjunda Swamy Shivananju1*

1Department of Biotechnology, JSS Science and Technology University, Sri Jayachamarajendra College of Engineering, JSS Technical Institutions Campus, Mysuru-570006, Karnataka, India
2Department of Microbiology, JSS Academy of Higher Education and Research, Mysuru-570015, Karnataka, India
3Department of Studies in Chemistry, University of Mysore, Manasagangotri, Mysuru-570006, Karnataka, India
4Department of Biotechnology and Bioinformatics, JSS Academy of Higher Education and Research, Mysuru-570015, Karnataka, India

ABSTRACT

Keywords:

How to cite this article: Swamy SG, Ramesh V, Gangatikar M, Srinivasa S, Priya BS, Siddaraju R, Shivamallu C, P HB, Shreevatsa B, Shivananju NS, Pharmacological Characterization of a Substituted Pyrrolizidine Derivative as a Dual Inhibitor of JAK1 Kinase and Pseudokinase Domains in Hepatocellular Carcinoma. Int J Drug Deliv Technol. 2026;16(2s): 465-474; DOI: 10.25258/ijddt.16.465-474